why choose us

First received: January 03, 2023

Clinical Trial: Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Colorectal Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase I/II Trial of Botensilimab, Balstilimab and Regorafenib (BBR) in Patients With Microsatellite Stable (MSS) Metastatic Colorectal Cancer Who Progressed on Prior Chemotherapy

Brief Summary: This phase I/II trial tests how well botensilimab, balstilimab, and regorafenib works in treating patients with microsatellite stable colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and who have progressed on prior chemotherapy.Immunotherapy with monoclonal antibodies, such as botensilimab and balstilimab, may help the…

Read more